CANNAINVESTOR Magazine February / March 2017 - Page 26


Best Practice = High Quality Medicines

Zelda has put in place a number of relationships providing a diversified, global supply chain to source the required cannabis medicine in a number of jurisdictions including Australia, North & South America and Europe. This is a critical aspect for any company operating in the cannabis sector given the legal complexities and logistical challenges of moving product across the globe.

With these supply arrangements in place, Zelda has secured a sustainable, high quality supply chain.

It’s Australian supplier, AusCann, is positioned as the premier group in the Australian sector. AusCann has international strategic partnerships with key global players in the production of medical cannabis. These include partnerships with Canadian company Canopy Growth Corporation and Chilean group Fundacion Daya, who are both prominent in the production of medical cannabis and renowned for using world’s best practice in quality assurance, agronomy and extraction technologies.

The founders of Zelda are also founders of AusCann providing even greater comfort that these commercial relationships provide a significant strategic advantage to Zelda.